Bicycle Return on Invested Capital from 2010 to 2024

BCYC Stock  USD 24.90  0.35  1.43%   
Check Bicycle Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bicycle main balance sheet or income statement drivers, such as Tax Provision of 1.5 M, Interest Income of 14.7 M or Discontinued Operations of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 40.62, Dividend Yield of 0.0 or Operating Cycle of 310. Bicycle financial statements analysis is a perfect complement when working with Bicycle Therapeutics Valuation or Volatility modules.
  
This module can also supplement Bicycle Therapeutics' financial leverage analysis and stock options assessment as well as various Bicycle Therapeutics Technical models . Check out the analysis of Bicycle Therapeutics Correlation against competitors.
For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.

About Bicycle Therapeutics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Bicycle Therapeutics income statement, its balance sheet, and the statement of cash flows. Bicycle Therapeutics investors use historical funamental indicators, such as Bicycle Therapeutics's Return on Invested Capital, to determine how well the company is positioned to perform in the future. Although Bicycle Therapeutics investors may use each financial statement separately, they are all related. The changes in Bicycle Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bicycle Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bicycle Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bicycle Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Bicycle Therapeutics plc was incorporated in 2009 and is headquartered in Cambridge, the United Kingdom. Bicycle Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 119 people.

Bicycle Therapeutics Investors Sentiment

The influence of Bicycle Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bicycle. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Bicycle Therapeutics' public news can be used to forecast risks associated with an investment in Bicycle. The trend in average sentiment can be used to explain how an investor holding Bicycle can time the market purely based on public headlines and social activities around Bicycle Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bicycle Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bicycle Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Bicycle Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Bicycle Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bicycle Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bicycle Therapeutics' short interest history, or implied volatility extrapolated from Bicycle Therapeutics options trading.

Pair Trading with Bicycle Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bicycle Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bicycle Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bicycle Stock

  0.71MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr

Moving against Bicycle Stock

  0.77KA Kineta Inc Financial Report 9th of May 2024 PairCorr
  0.73ME 23Andme HoldingPairCorr
  0.71VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
  0.7MEIP MEI Pharma Financial Report 9th of May 2024 PairCorr
  0.66MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to Bicycle Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bicycle Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bicycle Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bicycle Therapeutics to buy it.
The correlation of Bicycle Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bicycle Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bicycle Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bicycle Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bicycle Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bicycle Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bicycle Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bicycle Therapeutics Stock:
Check out the analysis of Bicycle Therapeutics Correlation against competitors.
For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Bicycle Stock analysis

When running Bicycle Therapeutics' price analysis, check to measure Bicycle Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicycle Therapeutics is operating at the current time. Most of Bicycle Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicycle Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicycle Therapeutics' price. Additionally, you may evaluate how the addition of Bicycle Therapeutics to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Is Bicycle Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bicycle Therapeutics. If investors know Bicycle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bicycle Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.08)
Revenue Per Share
0.758
Quarterly Revenue Growth
0.674
Return On Assets
(0.24)
Return On Equity
(0.56)
The market value of Bicycle Therapeutics is measured differently than its book value, which is the value of Bicycle that is recorded on the company's balance sheet. Investors also form their own opinion of Bicycle Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Bicycle Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bicycle Therapeutics' market value can be influenced by many factors that don't directly affect Bicycle Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bicycle Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bicycle Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bicycle Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.